Iyoda Masayuki, Hayashi Fumihiro, Kuroki Aki, Shibata Takanori, Kitazawa Kozo, Sugisaki Tetsuzo, Sakai Osamu
Department of Internal Medicine, Tokyu Hospital, Tokyo, Japan.
Am J Kidney Dis. 2003 Sep;42(3):E11-3. doi: 10.1016/s0272-6386(03)00796-0.
The authors present a case of acquired reactive perforating collagenosis developed in a nondiabetic hemodialysis patient, who was treated successfully with allopurinol. Treatment of acquired reactive perforating collagenosis is difficult and often ineffective. The patient had been unresponsive to conventional treatments, but the pruritus was controlled, and skin lesions subsequently resolved after the treatment with allopurinol. Possible mechanisms of allopurinol treatment for acquired reactive perforating collagenosis are discussed.
作者报告了一例非糖尿病血液透析患者发生的获得性反应性穿通性胶原病,该患者用别嘌醇成功治愈。获得性反应性穿通性胶原病的治疗困难且往往无效。该患者对传统治疗无反应,但瘙痒得到控制,使用别嘌醇治疗后皮肤病变随后消退。本文讨论了别嘌醇治疗获得性反应性穿通性胶原病的可能机制。